|
|
|

|

|
| |
February 29th, 2008: Acquisition of Verdera Oy
Montréal, Canada / Espoo, Finland
- We are proud to announce that Lallemand acquired Verdera Oy in
the early days of February.
Verdera Oy is a finnish company
specializing in sustainable biological solutions for the
forestry, horticulture and turf grass segments: they develop,
manufacture and market bio-pesticides and growth stimulants for
plant care uses. They export the products to more than 15
countries all over the world, primarily in Europe, North America
and Asia.

For more
details please visit
www.verdera.fi
back
to top
February 22nd, 2008:
Creation of Lallemand Pharma International
Montréal, Canada / Lugano,
Switzerland - We are pleased to announce that
Lallemand Pharma International AG (LPI - Switzerland), a new
affiliate of Lallemand dedicated exclusively to the clinical
studies, registrations, marketing and sales of pharmaceutical
products, was created in the early days of February. It acquired
the business and intellectual property rights of the drug sold
under the brands Ismigen and Immubron in various countries
around the world. Istituto Pirri, the original owner, still
remains a partner and shareholder of LPI.

The primary objective of LPI will be to develop and sell a
range of bacterial lysates (Ismigen, Immubron, Bromunyl) that
Lallemand has been producing at its St Simon facility for the
last 15 years. The specificity of Lallemand's lysates is that
they are produced from a complete range of inactivated
pathogenic bacteria that undergo a mechanical lysis. This
original and unique process gives the drug a far stronger
immunogenic power than other lysates presently on the market.
They target respiratory infections, which are currently
developing and believed to become a major cause of disease by
2020.
For now Ismigen is sold in Italy, Portugal, Mexico, Uruguay
and Chile, and is under registration in a few other counties. As
far as 2008 is concerned, the priority countries to develop will
be Ukraine and CIS countries, South America, Turkey and India.
back
to top
October 30th, 2007: Kemira GrowHow sells
Verdera
Espoo, Finland - Kemira
GrowHow Oyj has today signed an agreement to sell 100% of the
shares of Verdera Oy to the Canadian Lallemand Group. The
closing of the agreement is expected to take place during the
first quarter of 2008.
Verdera Oy produces biological plant protection products
for forestry, horticulture and amenity needs. Verdera’s turnover
was approximately two million euros in 2006 and the company has
13 employees.
Heiki Sirviö, Chief Executive Officer,
Kemira GrowHow Oyj
For additional information:
Kaj Friman, CFO
Tel: +358 50 62 626
back to top
October 29th, 2007: V&S To Sell Yeast Operation
Grenå, Denmark - V&S Group
has signed an agreement to sell a yeast production facility in
Grenaa, Denmark, to the Canadian company Lallemand Inc., one of
the world’s leading producers and marketers of yeast. This is
part of V&S Group’s strategy to focus on branded spirits.
The operation in Grenaa produces yeast and molasses
alcohol, primarily for the Danish market. It employs a staff of
81 and in 2006 sales reached approximately SEK 230m.
Further information:
Jacob Broberg, Senior Vice-President,
Corporate Affairs & Communication, V&S:
jacob.broberg@vsgroup.com
Peeter Luksep, Vice-President, Investor Relations, V&S:
peeter.luksep@vsgroup.com
back
to top
click here to download ADOBE® READER™ to read PDFs if
required.
|
|
|